WATERS CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 397 BRL | +0.76% |
|
+0.76% | -20.28% |
| 02/07 | Evercore ISI Adjusts Price Target on Waters to $300 From $320, Maintains In-Line Rating | MT |
| 27/06 | Barclays Adjusts Price Target on Waters to $275 From $295 | MT |
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The group's activity appears highly profitable thanks to its outperforming net margins.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- According to forecast, a sluggish sales growth is expected for the next fiscal years.
- With a 2024 P/E ratio at 26.34 times the estimated earnings, the company operates at rather significant levels of earnings multiples.
- Based on current prices, the company has particularly high valuation levels.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- Over the past twelve months, analysts' opinions have been revised negatively.
Ratings chart - Surperformance
Sector: Advanced Medical Equipment & Technology
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| -20.28% | 1.68TCr | - | ||
| +0.59% | 21TCr | B | ||
| +3.92% | 18TCr | B- | ||
| +30.07% | 15TCr | B- | ||
| +32.42% | 11TCr | A- | ||
| +1.98% | 6.44TCr | A- | ||
| +19.65% | 5.44TCr | B+ | ||
| -1.86% | 4.74TCr | B+ | ||
| -9.53% | 3.72TCr | A | ||
| -1.28% | 3.48TCr | - |
Investor Rating
Trading Rating
ESG Refinitiv
-
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
Valuation
P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield
-
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion
Business Predictability
Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- WAT Stock
- WATC34 Stock
- Ratings Waters Corporation
